These data demonstrate that the OGF-OGFr axis is present in follicular-derived thyroid cancers, and that OGF is a tonically active inhibitory peptide that serves in a receptor-mediated manner to repress proliferation of these thyroid cancer cells. Here, OGFR is linked to thyroid gland carcinoma.